Partner Content Partner Content Superbugs & Superdrugs USA Conference returns to New Jer... Superbugs & Superdrugs USA Conference, Nov 2018
Views & Analysis Medtech is key in fight against AMR Paul Chapman examines the challenge of antimicrobial resistance (AMR) and how it could be beaten.
Partner Content Partner Content AMR research, funding and incentives – updates at SMi event ... SMi reports: Antimicrobial resistance was predicted by Alexander Fleming in his Nobel lecture (1945).
News UK and Russian experts tackle superbugs The AMR Centre is to collaborate with Russia's Skolkovo Foundation
Partner Content Partner Content “SPARKing" New Antibiotic Drug Discovery “SPARKing" New Antibiotic Drug Discovery
Partner Content Partner Content Superbugs: Exclusive Interviews Released with ABAC Therapeut... Q&A's Out Ahead of Superbugs 2018
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
